CM Life Sciences II Inc. Unit
CMIIU
CMIIU was delisted on the 1st of September, 2021.
0 hedge funds and large institutions have $0 invested in CM Life Sciences II Inc. Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 38 closing their positions.
100% less funds holding
Funds holding: 38 → 0 (-38)
100% less capital invested
Capital invested by funds: $237M → $0 (-$237M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 38
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$38.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$22.3M |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$20.6M |
| 4 |
PA
Perceptive Advisors
New York
|
-$16.8M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$14.1M |
CMIIU Hedge Fund Activity: Q3 2021 in Review
0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q3 2021, worth a combined $0 — down 100% from $237M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CMIIU and 0 opened new positions — a net loss of 38 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was ARK Investment Management, exiting entirely with an estimated $38.3M sold.
- 0 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q3 2021, down from 38 in Q2 2021.
- Funds reported $0 of CM Life Sciences II Inc. Unit stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new CM Life Sciences II Inc. Unit positions in Q3 2021 and 38 closed out, a net change of -38 holders.
- The largest CM Life Sciences II Inc. Unit seller in Q3 2021 was ARK Investment Management, an estimated $38.3M sold.
Based on aggregated 13F filings for Q3 2021.